Modern mammography screening and breast cancer mortality: population study
Open Access
- 17 June 2014
- Vol. 348 (jun17 17), g3701
- https://doi.org/10.1136/bmj.g3701
Abstract
Objective To evaluate the effectiveness of contemporary mammography screening using individual information about screening history and breast cancer mortality from public screening programmes. Design Prospective cohort study of Norwegian women who were followed between 1986 and 2009. Within that period (1995-2005), a national mammography screening programme was gradually implemented, with biennial invitations sent to women aged 50-69 years. Participants All Norwegian women aged 50-79 between 1986 and 2009. Main outcome measures Multiple Poisson regression analysis was used to estimate breast cancer mortality rate ratios comparing women who were invited to screening (intention to screen) with women who were not invited, with a clear distinction between cases of breast cancer diagnosed before (without potential for screening effect) and after (with potential for screening effect) the first invitation for screening. We took competing causes of death into account by censoring women from further follow-up who died from other causes. Based on the observed mortality reduction combined with the all cause and breast cancer specific mortality in Norway in 2009, we used the CISNET (Cancer Intervention and Surveillance Modeling Network) Stanford simulation model to estimate how many women would need to be invited to biennial mammography screening in the age group 50-69 years to prevent one breast cancer death during their lifetime. Results During 15 193 034 person years of observation (1986-2009), deaths from breast cancer occurred in 1175 women with a diagnosis after being invited to screening and 8996 women who had not been invited before diagnosis. After adjustment for age, birth cohort, county of residence, and national trends in deaths from breast cancer, the mortality rate ratio associated with being invited to mammography screening was 0.72 (95% confidence interval 0.64 to 0.79). To prevent one death from breast cancer, 368 (95% confidence interval 266 to 508) women would need to be invited to screening. Conclusion Invitation to modern mammography screening may reduce deaths from breast cancer by about 28%.This publication has 31 references indexed in Scilit:
- Overdiagnosis among women attending a population‐based mammography screening programInternational Journal of Cancer, 2013
- Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality databaseBMJ, 2011
- Mammography activity in Norway 1983 to 2008Acta Oncologica, 2011
- Breast cancer mortality in organised mammography screening in Denmark: comparative studyBMJ, 2010
- NORDCAN – a Nordic tool for cancer information, planning, quality control and researchActa Oncologica, 2010
- Comparing Screening Mammography for Early Breast Cancer Detection in Vermont and NorwayJNCI Journal of the National Cancer Institute, 2008
- Estimating The Benefits of Mammography ScreeningEpidemiology, 2007
- Effect of Screening and Adjuvant Therapy on Mortality from Breast CancerThe New England Journal of Medicine, 2005
- Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort studyBMJ, 2005
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerThe New England Journal of Medicine, 1988